A detailed history of Kestra Advisory Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 90,521 shares of LLY stock, worth $72.2 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
90,521
Previous 75,680 19.61%
Holding current value
$72.2 Million
Previous $58.9 Million 39.2%
% of portfolio
0.47%
Previous 0.41%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $10.8 Million - $13.5 Million
14,841 Added 19.61%
90,521 $82 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $6.13 Million - $8.21 Million
10,359 Added 15.86%
75,680 $58.9 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $3.33 Million - $3.93 Million
6,343 Added 10.75%
65,321 $38.1 Million
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $665,525 - $917,528
1,531 Added 2.67%
58,978 $31.7 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $119,953 - $160,391
342 Added 0.6%
57,447 $26.9 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $5.13 Million - $6.03 Million
-16,527 Reduced 22.45%
57,105 $19.6 Million
Q4 2022

Jan 31, 2023

BUY
$321.55 - $374.67 $2.5 Million - $2.92 Million
7,786 Added 11.82%
73,632 $26.9 Million
Q3 2022

Nov 01, 2022

SELL
$296.48 - $337.87 $3.01 Million - $3.43 Million
-10,150 Reduced 13.36%
65,846 $21.3 Billion
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $6.71 Million - $7.87 Million
24,058 Added 46.32%
75,996 $24.6 Million
Q1 2022

Apr 26, 2022

BUY
$234.69 - $291.66 $911,301 - $1.13 Million
3,883 Added 8.08%
51,938 $14.9 Million
Q4 2021

Jan 20, 2022

BUY
$224.85 - $279.04 $655,887 - $813,959
2,917 Added 6.46%
48,055 $13.3 Million
Q3 2021

Oct 19, 2021

SELL
$221.6 - $272.71 $316,444 - $389,429
-1,428 Reduced 3.07%
45,138 $10.4 Million
Q2 2021

Jul 28, 2021

BUY
$180.55 - $233.54 $269,561 - $348,675
1,493 Added 3.31%
46,566 $10.7 Million
Q1 2021

May 10, 2021

SELL
$164.32 - $212.72 $2.88 Million - $3.73 Million
-17,525 Reduced 28.0%
45,073 $8.42 Million
Q4 2020

Jan 20, 2021

BUY
$130.46 - $172.63 $2.41 Million - $3.19 Million
18,467 Added 41.85%
62,598 $10.5 Billion
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $6.45 Million - $7.46 Million
44,131 New
44,131 $6.53 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $758B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.